Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1651487

registered interest
date	10/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Standards
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the level of support available under the Pharmacy Access Scheme; and whether the criteria includes the (1) quality, (2) opening hours, and (3) range of provision, of existing pharmacies.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL9200
answer	answer is ministerial correction date of answer 19/07/2023 answer text <p><del class="ministerial">The early access to medicines scheme (EAMS) aims to give patients with life threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation when there is a clear unmet medical need.</del></p><p><del class="ministerial">Under the scheme, the Medicines and Healthcare products Regulatory Agency (MHRA) will give a scientific opinion on the benefit/risk balance of the medicine, based on the data available when the EAMS submission was made and the EAMS criteria. The MHRA will make an evaluation of products, including drugs such as for brain tumour treatments, once an application is received.</del></p><p><del class="ministerial">If we do receive an application, it is only made public where an EAMS Scientific Opinion (SO) is awarded. All EAMS SOs are published on the EAMS webpage. All drugs that have previously held an EAMS SO are also published on the EAMS webpage.</del></p><p><ins class="ministerial">The Pharmacy Access Scheme provides additional funding to pharmacies where the next nearest pharmacy is more than a 20-minute walk away. This is calculated as a 0.8-mile walking distance in areas of high deprivation and 1 mile in other areas. In 2021, we agreed updated eligibility criteria and an updated payment model with Community Pharmacy England. To be eligible for the payment, pharmacies must deliver the Community Pharmacist Consultation Service. Quality and opening hours are not included in the eligibility criteria.</ins></p><p> </p><p> </p> answering member printed Lord Markham question first answered 19/07/2023 15:05:50 question first ministerially corrected 20/07/2023 15:18:01 answering member 4948 label Biography information for Lord Markham previous answer version 88780 answering member printed Lord Markham answering member 4948 label Biography information for Lord Markham
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1650136

registered interest
date	04/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Processed Food
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what discussions they are having with (1) UK medical professionals and scientists, and (2) international partners, about (a) developing, and (b) agreeing, internationally recognised definitions of ultra-processed food.
tabling member printed	Baroness Suttie
uin	HL9040
answer	answer is ministerial correction date of answer 10/07/2023 answer text <p><del class="ministerial">The Government has no plans.</del></p><p><ins class="ministerial">The Scientific Advisory Committee on Nutrition (SACN) is currently carrying out a scoping review of the evidence on processed foods and health and aims to publish its initial assessment in the summer of 2023. SACN’s scoping review will make a number of research recommendations in this area. This review will also include evaluating existing classifications of processed foods, including ultra-processed foods and the NOVA classification.</ins></p><p><ins class="ministerial">SACN is a committee of the Office for Health Improvement and Disparities (OHID) and provides independent scientific advice and risk assessments on nutrition and related health issues. Members of SACN are appointed as independent scientific experts in their field. We are not aware of any plans to agree a definition internationally.</ins></p><p><ins class="ministerial">The Department funds research on health and social care through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health including ultra-processed foods. The usual practice of the NIHR is not to ring-fence funds for expenditure on particular topics.</ins></p> answering member printed Lord Markham question first answered 10/07/2023 16:22:27 question first ministerially corrected 13/07/2023 14:43:31 answering member 4948 label Biography information for Lord Markham previous answer version 86576 answering member printed Lord Bethell answering member 4708
tabling member	4298 label Biography information for Baroness Suttie

1650137

registered interest
date	04/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Processed Food
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what plans they have to carry out research into the impact of ultra-processed foods on public health outcomes.
tabling member printed	Baroness Suttie
uin	HL9041
answer	answer is ministerial correction date of answer 10/07/2023 answer text <p><del class="ministerial">The Government has no plans.</del></p><p><ins class="ministerial">The Scientific Advisory Committee on Nutrition (SACN) is currently carrying out a scoping review of the evidence on processed foods and health and aims to publish its initial assessment in the summer of 2023. SACN’s scoping review will make a number of research recommendations in this area. This review will also include evaluating existing classifications of processed foods, including ultra-processed foods and the NOVA classification.</ins></p><p><ins class="ministerial">SACN is a committee of the Office for Health Improvement and Disparities (OHID) and provides independent scientific advice and risk assessments on nutrition and related health issues. Members of SACN are appointed as independent scientific experts in their field. We are not aware of any plans to agree a definition internationally.</ins></p><p><ins class="ministerial">The Department funds research on health and social care through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health including ultra-processed foods. The usual practice of the NIHR is not to ring-fence funds for expenditure on particular topics.</ins></p> answering member printed Lord Markham question first answered 10/07/2023 16:22:27 question first ministerially corrected 20/07/2023 15:18:27 answering member 4948 label Biography information for Lord Markham previous answer version 86577 answering member printed Lord Bethell answering member 4708
tabling member	4298 label Biography information for Baroness Suttie

1649604

registered interest
date	03/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the percentage of seasonal flu vaccinations which can be delivered by (a) Community Pharmacies, (b) General Practice, (c) other providers.
tabling member constituency	Knowsley
tabling member printed	Sir George Howarth
uin	192008
answer	answer is ministerial correction date of answer 11/07/2023 answer text <p>NHS providers determine how many seasonal flu vaccines to buy each year based on their local populations, eligible cohorts and uptake ambitions for the NHS programme as outlined in the annual flu system letter. The letter, published on the 25 May 2023, is based on the advice of the Joint Committee on Vaccination and Immunisation (JCVI) who review the latest evidence on flu vaccines and advise on the type of vaccine to be offered to different age groups and on which vaccines should be prioritised for various at-risk groups.</p><p>General Practitioners and community pharmacists are responsible for ordering their own flu vaccines for the adult population from suppliers. These are then used to deliver the national flu vaccination programme, with deliveries phased through the season to help mitigate against risks of wastage, cold chain failure and to adequately cover the peaks and flows of local demand. In addition, Hospital Trusts are commissioned at local discretion, to further support delivery of the national flu vaccination programme, for example to women who are pregnant, long stay in-patients and those accessing outpatients' services.</p><p>School Age Immunisation Services (SAIS) are commissioned regionally to deliver the school aged influenza programme in line with the annual flu system letter and amendment published on the July 3, 2023. The school age programme for 2023/24 includes primary school aged children from Reception to Year 6 and secondary school-aged children in Years 7, 8, 9, 10 and 11. Vaccines for the children’s programme are procured nationally with SAIS</p><p><del class="ministerial">TARGET DATE 11/07/2023</del></p><p>providers responsible for drawing down their own vaccines according to their schedules, capacity and demand, with deliveries phased through the season to help mitigate against risks of wastage and cold chain failure.</p><p>For in detail seasonal influenza percentage uptake delivered by (a) Community Pharmacies, (b) General Practice, (c) other providers please see page 41 and 42 of the following link: <del class="ministerial">Seasonal influenza vaccine uptake in GP patients: winter season 2022 to 2023 (publishing.service.gov.uk)</del></p><p><ins class="ministerial"><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1164871/GP-patients-flu-annual-report-2022-2023.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1164871/GP-patients-flu-annual-report-2022-2023.pdf</a></ins></p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 11/07/2023 16:13:38 question first ministerially corrected 12/07/2023 08:23:43 answering member 4492 label Biography information for Maria Caulfield previous answer version 87011 answering member constituency Lewes answering member printed Maria Caulfield answering member 4492 label Biography information for Maria Caulfield
tabling member	481 label Biography information for Sir George Howarth

1648716

registered interest
date	28/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Screening: Age
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what are the age limits on each of the NHS screening programmes and the justification for each limit.
tabling member printed	Lord Hunt of Kings Heath
uin	HL8877
answer	answer is ministerial correction date of answer 12/07/2023 answer text <p>All National screening programmes are introduced based on recommendations made by the UK National Screening Committee (UK NSC). The UK NSC assesses and evaluates the evidence to offer screening when it will offer more good than harm. Screening age ranges are selected based on the range where the evidence supports that balance.</p><p>The National Health Service breast screening programme invites eligible women to be screened every three years from the age of 50 up to their 71st birthday.</p><p>The NHS bowel screening programme invited men and women every two years from ages 60 to 74 years old. The programme is expanding to make it available to everyone aged 50 to 59 years old. This is happening gradually over four years and started in April 2021.</p><p>The NHS cervical screening programme invites people with a cervix between the ages of 25 and 49 for screening every three years, whilst people aged 50 to 64 receive an invitation every five years.</p><p>The NHS abdominal aortic aneurysm screening programme offers men a screening the year they turn 65.</p><p>The NHS diabetic eye screening programme is offered to anyone with diabetes who is 12 years old or over. Those eligible are invited for an annual screening.</p><p>The NHS targeted lung cancer screening programme that has been recently announced will invite people aged 55 to 74 identified as being at high risk of lung cancer for screening.</p><p>For antenatal screening programmes, pregnant women are invited early for screening once the pregnancy has been confirmed. This includes the NHS foetal anomaly screening programme and NHS infectious diseases in pregnancy.</p><p><ins class="ministerial"> <p><ins class="ministerial">Screening for newborns is also offered early at a time when conditions can be detected and where early treatment can improve the baby’s health and prevent severe disability or even death. Newborn screening programmes include the NHS newborn blood spot screening programme, the NHS newborn hearing screening programme, the NHS newborn and infant physical examination screening programme and the NHS sickle cell and thalassaemia screening programme.</ins></p></ins></p> answering member printed Lord Markham question first answered 12/07/2023 13:22:33 question first ministerially corrected 20/07/2023 15:18:13 answering member 4948 label Biography information for Lord Markham previous answer version 87138 answering member printed Lord Markham answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1644491

registered interest
date	13/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Integrated Care boards
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what is their policy justification for deciding not to define an integrated care board as a “relevant body” in regulation 2 of the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the effect that a range of patient rights formerly imposed on clinical commissioning groups are not now imposed on integrated care boards.
tabling member printed	Lord Hunt of Kings Heath
uin	HL8440
answer	answer is ministerial correction date of answer 27/06/2023 answer text <p><del class="ministerial">‘The National Health Service (Integrated Care Boards: Responsibilities) Regulations 2022’</del><ins class="ministerial"> The Health and Care Act 2022 (Consequential and Related Amendments and Transitional Provisions) Regulations 2022 SI/634</ins> has made consequential amendments to regulation 2 of the NHS Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, replacing references to Clinical Commissioning Groups with integrated care boards (ICBs). ICBs are now the statutory bodies responsible for patient rights.</p> answering member printed Lord Markham question first answered 27/06/2023 16:18:31 question first ministerially corrected 26/07/2023 13:28:18 answering member 4948 label Biography information for Lord Markham previous answer version 84191 answering member printed Lord Markham answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1639305

registered interest
date	22/05/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Liver Diseases: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of introducing FibroScans in primary care to improve early diagnosis of non-alcohol related fatty liver disease.
tabling member constituency	Darlington
tabling member printed	Peter Gibson
uin	186182
answer	answer is ministerial correction date of answer 30/05/2023 answer text <p>The Department has not made a specific assessment of the potential merits of introducing FibroScans in primary care to improve early diagnosis of non-alcohol related fatty liver disease. However, a practice has clinical discretion to decide if a FibroScan is necessary and appropriate for a patient and can either provide directly or through a provider, typically a hospital out-patient appointment.</p><p><ins class="ministerial"> <p><ins class="ministerial">In addition, NHS England have confirmed they have begun to assess the introduction of FibroScans through Community Diagnostic Centres. £2.3 billion is being spent to increase the number of Community Diagnostic Centres by March 2025, these centres will offer a range of services, with some providing services to support liver diagnosis . This will boost capacity to diagnose liver disease and improve earlier diagnosis and health outcomes.</ins></p></ins></p><p><del class="ministerial">In addition, NHS England have confirmed they have begun to assess the introduction of FibroScans through Community Diagnostic Centres. £2.3 billion is being spent to increase the number of Centres diagnosing liver disease to at least 100 sites by March 2025. This will boost diagnostic capacity to diagnose liver disease and improve earlier diagnosis and health outcomes.</del></p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 30/05/2023 14:08:29 question first ministerially corrected 11/07/2023 15:48:09 answering member 4527 label Biography information for Helen Whately previous answer version 77366 answering member constituency Faversham and Mid Kent answering member printed Helen Whately answering member 4527 label Biography information for Helen Whately
tabling member	4754 label Biography information for Peter Gibson

1608150

registered interest
date	28/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood and Organs: Donors
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 March 2023 to Question 170758 on Blood: Ethnic Groups, which languages literature relating to NHS blood and transplant donations is available in.
tabling member constituency	Stockport
tabling member printed	Navendu Mishra
uin	175672
answer	answer is ministerial correction date of answer 17/04/2023 answer text <p>NHS Blood and Transplant produces literature relating to donations in various languages including Welsh, Bengali, Gujarati, Hindi, Punjabi, Tamil, Urdu, Arabic, Somali, Polish, Romanian, French, Cantonese, Mandarin,<del class="ministerial"> Hebrew,</del> and Yiddish.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 17/04/2023 08:18:03 question first ministerially corrected 03/05/2023 08:29:27 answering member 4679 label Biography information for Neil O'Brien previous answer version 67678 answering member constituency Harborough answering member printed Neil O'Brien answering member 4679 label Biography information for Neil O'Brien
tabling member	4811 label Biography information for Navendu Mishra

1601933

registered interest
date	07/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Brain: Tumours
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of developing a strategic plan for the (a) funding and (b) other resourcing of (i) discovery, (ii) translational and (iii) clinical research into brain tumours.
tabling member constituency	Wigan
tabling member printed	Lisa Nandy
uin	160266
answer	answer is ministerial correction date of answer 13/03/2023 answer text <p><del class="ministerial">The Department has published its Health Infrastructure Plan in September 2019 that sets out the Government’s strategy and priorities for investing in the National Health Service estate, including in cancer centres. We are at present working on an update to this strategy through to 2030.</del></p><p><ins class="ministerial"> <p><ins class="ministerial">The Department-funded National Institute for Health and Care Research (NIHR) invests in research, clinical expertise, specialist facilities, workforce and support services across a range of clinical areas, including brain tumour research.</ins></p><p><ins class="ministerial">NIHR has recently announced the outcome of the Biomedical Research Centre (BRC) competition in which six BRCs have been funded to support brain tumour research. The NIHR BRCs works in partnership with other research centres such as the CRUK Brain Tumour Centre of Excellence to collect samples for research purposes as well as local and national sample storage facilities to support research into brain tumours.</ins></p></ins></p><p><del class="ministerial">Currently, we do not have a national capital programme strictly dedicated to cancer centres. However, there are several programmes, including the Targeted Investment Fund, the New Hospital Programme and the Hospital Upgrades Programme, that are funding upgrades to existing cancer centres. These schemes are assessed on a case-by-case basis.</del></p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 13/03/2023 11:09:49 question first ministerially corrected 14/03/2023 10:37:25 answering member 4527 label Biography information for Helen Whately previous answer version 61183 answering member constituency Faversham and Mid Kent answering member printed Helen Whately answering member 4527 label Biography information for Helen Whately
tabling member	4082 label Biography information for Lisa Nandy

1601411

registered interest
date	06/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Consultants: Expenditure
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the cost to the public purse was of spending on external consultants by (a) the Medicines and Healthcare products Regulatory Agency, (b) the UK Health Security Agency, (c) NHS England, and (d) NHS Digital in (i) 2020, (ii) 2021 and (iii) 2022; and whether any of that spending related to the preparation of funding bids to (A) his Department and (B) HM Treasury.
tabling member constituency	Islington South and Finsbury
tabling member printed	Emily Thornberry
uin	158842
answer	answer is ministerial correction date of answer 30/03/2023 answer text <p><strong>Suggested reply</strong></p><p>The following table shows the expenditure on consultancy on external consultants in the financial years 2019/20 to 2021/22. Expenditure values for 2022/23 are not yet available. The Department does not hold the detail behind the expenditure.</p><table><tbody><tr><td rowspan="2"><p>Organisation</p></td><td colspan="3"><p>Expenditure on consultancy (£ million)</p></td></tr><tr><td><p>2019/20</p></td><td><p>2020/21</p></td><td><p>2021/22</p></td></tr><tr><td><p>Medicines and Healthcare products Regulatory Agency (MHRA)</p></td><td><p><del class="ministerial">Not available</del> <ins class="ministerial">0.3</ins></p></td><td><p><del class="ministerial">Not available</del> <ins class="ministerial">0.8</ins></p></td><td><p><del class="ministerial">Not available</del> <ins class="ministerial">6.4</ins></p></td></tr><tr><td><p>UK Health Security Agency (UKHSA)</p></td><td><p>Not applicable</p></td><td><p>Not applicable</p></td><td><p>10.0</p></td></tr><tr><td><p>NHS England - Group</p></td><td><p>45.8</p></td><td><p>51.6</p></td><td><p>75.8</p></td></tr><tr><td><p>NHS Digital</p></td><td><p>1.4</p></td><td><p>0.9</p></td><td><p>0.3</p></td></tr></tbody></table><p> </p><p>Note:</p><ol><li>The definition for consultancy is in line with HM Treasury Guidance</li><li>The Office for National Statistics re-categorised MHRA as falling within the Departmental Group from April 2022. In years 2019/20, 2020/21 and 2021/22 this body was not incorporated into the Department’s accounting boundary and, therefore, the Department does not hold requested data.</li><li>UKHSA was formed in April 2021 and became fully operational in October 2021.</li></ol><p>Source:</p><p>UK Health Security Agency Annual Report and Accounts 2021/22.</p><p>NHS Commissioning Board Annual Report and Accounts 2019/20, 2020/21 and 2021/22. Expenditure for the NHSE Group including Commissioning Support Units and Clinical Commissioning Groups (CCGs).</p><p>NHS Digital Annual Report and Accounts 2019/20, 2020/21 and 2021/22.</p> answering member constituency Colchester answering member printed Will Quince question first answered 30/03/2023 14:37:21 question first ministerially corrected 04/04/2023 11:16:39 answering member 4423 label Biography information for Will Quince previous answer version 66497 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
tabling member	1536 label Biography information for Emily Thornberry